2,4-dichloro-6-[3-(5-ethyl-1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine
Structure Info
- Chemspace ID
- CSSB21332060749 (In-Stock Building Blocks)
- IUPAC Name
- 2,4-dichloro-6-[3-(5-ethyl-1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine
- Mol formula
- C12H14Cl2N6O
- Mol weight
- 329 Da
- Catalog Number(s)
- BBLS21332060749, EN300-55005070, bbls21332060749
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.85
- Heavy atoms count
- 21
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.58333333333333
- Polar surface area (Å)
- 81
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 0
![Chemical structure of 2,4-dichloro-6-[3-(5-ethyl-1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine (C12H14Cl2N6O) - CSSB21332060749](/st/structure/200/c8fb6e84ffc402a4da117640d44d6633/CCC1%253DNC%2528%253DNO1%2529C1CCCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png "C12H14Cl2N6O")
- Zoom the structure
- CSSB21332060749
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine - CSSB20732621820](/st/structure/200/11d50355431586c415203ff6db8806e4/CC1%253DNC%2528%253DNO1%2529C1CCCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332137437](/st/structure/200/14f3e230a8260d428a4f1ad7f9e16498/CC1%253DNC%2528%253DNO1%2529C1CCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-{3-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-1-yl}-1,3,5-triazine - CSSB21332129537](/st/structure/200/220bcaaf040a4c322be2aa08bd12b39f/CC1%253DNC%2528CC2CCCN%2528C2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529%253DNO1.png)
![Chemical structure of 2,4-dichloro-6-[3-(3-ethyl-1,2,4-oxadiazol-5-yl)azetidin-1-yl]-1,3,5-triazine - CSSB20454568927](/st/structure/200/d06a72af87b95adede8d29ed1bc5e9b4/CCC1%253DNOC%2528%253DN1%2529C1CN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[3-(1,2,4-oxadiazol-3-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332137191](/st/structure/200/567a2bc5e28f67129824fefea8b84940/ClC1%253DNC%2528%253DNC%2528Cl%2529%253DN1%2529N1CCCC%2528C1%2529C1%253DNOC%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332129395](/st/structure/200/a42c32ddd6e8d593a75c194d356808f9/CC1%253DNN%253DC%2528O1%2529C1CCCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,2,4-oxadiazol-3-yl)azetidin-1-yl]-1,3,5-triazine - CSSB21332128880](/st/structure/200/2456427dba00dff57fec1d474f5f82ff/CC1%253DNC%2528%253DNO1%2529C1CN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
